Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium-glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2019
|
| Sorozat: | NEW ENGLAND JOURNAL OF MEDICINE
380 No. 24 |
| Tárgyszavak: | |
| doi: | 10.1056/NEJMoa1811744 |
| mtmt: | 33677430 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/26664 |